These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 14520367)

  • 21. Tumor resistance to CD8+ T cell-based therapeutic vaccination.
    Huang Y; Shah S; Qiao L
    Arch Immunol Ther Exp (Warsz); 2007; 55(4):205-17. PubMed ID: 17659376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.
    Munn DH; Sharma MD; Baban B; Harding HP; Zhang Y; Ron D; Mellor AL
    Immunity; 2005 May; 22(5):633-42. PubMed ID: 15894280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review).
    Hoskin DW; Mader JS; Furlong SJ; Conrad DM; Blay J
    Int J Oncol; 2008 Mar; 32(3):527-35. PubMed ID: 18292929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of immune escape of cancer and its regulation.
    Morita R; Hirohashi Y; Torigoe T
    Rinsho Ketsueki; 2009 May; 50(5):375-80. PubMed ID: 19483397
    [No Abstract]   [Full Text] [Related]  

  • 25. Regulation of tryptophan metabolism in Pseudomonas by enzyme and permease induction and the allosteric control of tryptophan oxygenase.
    Feigelson P; Maeno H; Poillon WN; Rosenfeld H
    Med J Osaka Univ; 1968 Sep; 19(1):35-40. PubMed ID: 5710968
    [No Abstract]   [Full Text] [Related]  

  • 26. Antimicrobial and immunoregulatory properties of human tryptophan 2,3-dioxygenase.
    Schmidt SK; Müller A; Heseler K; Woite C; Spekker K; MacKenzie CR; Däubener W
    Eur J Immunol; 2009 Oct; 39(10):2755-64. PubMed ID: 19637229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo.
    Bauer TM; Jiga LP; Chuang JJ; Randazzo M; Opelz G; Terness P
    Transpl Int; 2005 Jan; 18(1):95-100. PubMed ID: 15612990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuronal localization of indoleamine 2,3-dioxygenase in mice.
    Roy EJ; Takikawa O; Kranz DM; Brown AR; Thomas DL
    Neurosci Lett; 2005 Oct; 387(2):95-9. PubMed ID: 16076525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cytotoxic T lymphocytes in cancer and autoimmunity].
    Prado-García H; Avila-Moreno F; López-González JS
    Rev Invest Clin; 2004; 56(5):629-39. PubMed ID: 15776868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
    Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M
    Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidepressant action of tryptophan.
    Young SN; Sourkes TL
    Lancet; 1974 Oct; 2(7885):897-8. PubMed ID: 4137543
    [No Abstract]   [Full Text] [Related]  

  • 32. Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants.
    van Hall T; Wolpert EZ; van Veelen P; Laban S; van der Veer M; Roseboom M; Bres S; Grufman P; de Ru A; Meiring H; de Jong A; Franken K; Teixeira A; Valentijn R; Drijfhout JW; Koning F; Camps M; Ossendorp F; Kärre K; Ljunggren HG; Melief CJ; Offringa R
    Nat Med; 2006 Apr; 12(4):417-24. PubMed ID: 16550190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indoleamine 2,3-dioxygenase (IDO) expression in invasive extravillous trophoblast supports role of the enzyme for materno-fetal tolerance.
    Hönig A; Rieger L; Kapp M; Sütterlin M; Dietl J; Kämmerer U
    J Reprod Immunol; 2004 Apr; 61(2):79-86. PubMed ID: 15063631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of allogeneic T-cell responses by dendritic cells expressing transduced indoleamine 2,3-dioxygenase.
    Funeshima N; Fujino M; Kitazawa Y; Hara Y; Hara Y; Hayakawa K; Okuyama T; Kimura H; Li XK
    J Gene Med; 2005 May; 7(5):565-75. PubMed ID: 15543532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma.
    Kumano M; Hara I; Furukawa J; Oniki S; Nagai H; Miyake H; Fujisawa M
    J Urol; 2007 Oct; 178(4 Pt 1):1504-9. PubMed ID: 17707061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of tumor escape: role of tumor microenvironment in inducing apoptosis of cytolytic effector cells.
    Poggi A; Zocchi MR
    Arch Immunol Ther Exp (Warsz); 2006; 54(5):323-33. PubMed ID: 17031467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutants escape from killer T cells, invade population.
    Wodarz D
    Nat Med; 2003 Oct; 9(10):1254-5. PubMed ID: 14520368
    [No Abstract]   [Full Text] [Related]  

  • 38. PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells.
    Iwai Y; Terawaki S; Honjo T
    Int Immunol; 2005 Feb; 17(2):133-44. PubMed ID: 15611321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cellular and molecular basis of natural antitumor immunity in renal cell carcinoma patients.
    Schendel DJ; Falk CS; Frankenberger B; Noessner E; Schleypen J; Pohla H
    Urologe A; 2004 Sep; 43 Suppl 3():S133-5. PubMed ID: 15179552
    [No Abstract]   [Full Text] [Related]  

  • 40. Comment on "Reduced cytotoxic function of effector CD8+ T cells is responsible for indoleamine 2,3-dioxygenase-dependent immune suppression".
    Sørensen RB; thor Straten P; Andersen MH
    J Immunol; 2009 Nov; 183(10):6040. PubMed ID: 19890063
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.